Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Perrella

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
International Journal of Immunopathology and Pharmacology|February 27, 2003
Hepatic and peripheral T-lymphocyte patterns in patients with chronic hepatitis C infection: what correlation with histological activity?A Perrella, O Perrella, C Sbreglia, et al.
Arquivos De Neuro-Psiquiatria|June 1, 1992
Interleukin-6 and granulocyte macrophage-CSF in the cerebrospinal fluid from HIV infected subjects with involvement of the central nervous systemO Perrella, M Guerriero, E Izzo, et al.
European Neurology|January 1, 1993
Markers of activated T lymphocytes and T cell receptor gamma/delta+ in patients with multiple sclerosisO Perrella, P B Carrieri, R De Mercato, et al.
Acta Neurologica|August 1, 1992
Cytokines in the pathogenesis of multiple sclerosisP B Carrieri, A Maiorino, V Provitera, et al.
Journal of Chemotherapy (Florence, Italy)|February 1, 1996
Combined therapy with zidovudine, recombinant granulocyte colony stimulating factors and erythropoietin in asymptomatic HIV patientsO Perrella, E Finelli, A Perrella, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|September 1, 1992
[The possible risks of transmission of hematogenous viroses in a prison community]G Liguori, F Rossano, O Perrella, et al.
Digestive Diseases and Sciences|July 1, 2005
A clinical-morphological study on cholestatic presentation of nonalcoholic fatty liver diseaseP Sorrentino, G Tarantino, A Perrella, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 28, 2004
Low daily dosage of interferon for 1 year after HCV-related end-therapy response. A randomized-controlled studyG Tarantino, P Sorrentino, P Conca, et al.
Scandinavian Journal of Gastroenterology|December 9, 2009
Rapid virological response in peripheral blood mononuclear cells with an increase of hepatitis C virus-specific interferon-gamma production predisposes to sustained virological response in patients with chronic hepatitis C genotype 1 undergoing treatment with pegylated-interferon alpha 2a plus ribavirinA Perrella, C Sbreglia, L Atripaldi, et al.
International Journal of Clinical & Laboratory Research|January 1, 1994
What is the correlation between soluble CD23 and IgE levels in human immunodeficiency virus-1 infection?O Perrella, P B Carrieri, A Perrella, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
International Journal of Immunopathology and Pharmacology|February 27, 2003
Hepatic and peripheral T-lymphocyte patterns in patients with chronic hepatitis C infection: what correlation with histological activity?A Perrella, O Perrella, C Sbreglia, et al.
Arquivos De Neuro-Psiquiatria|June 1, 1992
Interleukin-6 and granulocyte macrophage-CSF in the cerebrospinal fluid from HIV infected subjects with involvement of the central nervous systemO Perrella, M Guerriero, E Izzo, et al.
European Neurology|January 1, 1993
Markers of activated T lymphocytes and T cell receptor gamma/delta+ in patients with multiple sclerosisO Perrella, P B Carrieri, R De Mercato, et al.
Acta Neurologica|August 1, 1992
Cytokines in the pathogenesis of multiple sclerosisP B Carrieri, A Maiorino, V Provitera, et al.
Journal of Chemotherapy (Florence, Italy)|February 1, 1996
Combined therapy with zidovudine, recombinant granulocyte colony stimulating factors and erythropoietin in asymptomatic HIV patientsO Perrella, E Finelli, A Perrella, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|September 1, 1992
[The possible risks of transmission of hematogenous viroses in a prison community]G Liguori, F Rossano, O Perrella, et al.
Digestive Diseases and Sciences|July 1, 2005
A clinical-morphological study on cholestatic presentation of nonalcoholic fatty liver diseaseP Sorrentino, G Tarantino, A Perrella, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 28, 2004
Low daily dosage of interferon for 1 year after HCV-related end-therapy response. A randomized-controlled studyG Tarantino, P Sorrentino, P Conca, et al.
Scandinavian Journal of Gastroenterology|December 9, 2009
Rapid virological response in peripheral blood mononuclear cells with an increase of hepatitis C virus-specific interferon-gamma production predisposes to sustained virological response in patients with chronic hepatitis C genotype 1 undergoing treatment with pegylated-interferon alpha 2a plus ribavirinA Perrella, C Sbreglia, L Atripaldi, et al.
International Journal of Clinical & Laboratory Research|January 1, 1994
What is the correlation between soluble CD23 and IgE levels in human immunodeficiency virus-1 infection?O Perrella, P B Carrieri, A Perrella, et al.
Pageof 5